These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30860148)

  • 1. A case of delayed-onset hereditary hemorrhagic telangiectasia with a frameshift ENG mutation.
    Akagawa H; Onda H; Nomura S; Shinohara T; Kasuya H
    Neurol India; 2019; 67(1):312-314. PubMed ID: 30860148
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutation c.263A>G in the ACVRL1 gene in a Japanese patient with hereditary hemorrhagic telangiectasia 2.
    Yaginuma A; Itoh M; Akasaka E; Nakano H; Sawamura D; Nakagawa H; Asahina A
    J Dermatol; 2019 Jan; 46(1):e22-e24. PubMed ID: 29923633
    [No Abstract]   [Full Text] [Related]  

  • 4. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].
    Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z
    Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia.
    Tørring PM; Kjeldsen AD; Ousager LB; Brusgaard K
    Mol Genet Genomic Med; 2018 Jan; 6(1):121-125. PubMed ID: 29243366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary hemorrhagic telangiectasia. Report of a pediatric case].
    Maaloul I; Aloulou H; Fourati H; Sfaihi L; Chabchoub I; Kamoun T; Mnif Z; Hachicha M
    Arch Pediatr; 2014 Jul; 21(7):768-71. PubMed ID: 24935454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a family mutation in the 5' untranslated region of the endoglin gene causative of hereditary hemorrhagic telangiectasia.
    Ruiz-Llorente L; McDonald J; Wooderchak-Donahue W; Briggs E; Chesnutt M; Bayrak-Toydemir P; Bernabeu C
    J Hum Genet; 2019 Apr; 64(4):333-339. PubMed ID: 30728427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
    Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
    Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Stratified Population Screening of Hereditary Hemorrhagic Telangiectasia.
    Major T; Gindele R; Szabó Z; Kis Z; Bora L; Jóni N; Bárdossy P; Rácz T; Bereczky Z
    Pathol Oncol Res; 2020 Oct; 26(4):2783-2788. PubMed ID: 30685840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.
    Sugden WW; Siekmann AF
    Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion/duplication analysis.
    McDonald J; Damjanovich K; Millson A; Wooderchak W; Chibuk JM; Stevenson DA; Gedge F; Bayrak-Toydemir P
    Clin Genet; 2011 Apr; 79(4):335-44. PubMed ID: 21158752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene diagnosis and treatment of hereditary hemorrhagic telangiectasia with epistaxis as its main symptom].
    Leng H; Zhang Q; Shi L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):591-592. PubMed ID: 31327192
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel frameshift mutation of the endoglin(ENG) gene causes hereditary hemorrhagic telangiectasia in a Chinese family.
    Li P; Gao C; Wei Y; Zhao X; Sun D; Lin L; Yang Y; Shao Q; Lv H
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):237-243. PubMed ID: 37603052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12q13.12q13.13 microdeletion encompassing ACVRL1 and SCN8A genes: Clinical report of a new contiguous gene syndrome.
    Poisson A; Lesca G; Chatron N; Favre E; Cottin V; Gamondes D; Sanlaville D; Edery P; Giraud S; Demily C; Dupuis-Girod S
    Eur J Med Genet; 2019 Nov; 62(11):103565. PubMed ID: 30389587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.
    Walsh LJ; Collins C; Ibrahim H; Kerins DM; Brady AP; O Connor TM
    J Med Case Rep; 2022 Mar; 16(1):99. PubMed ID: 35232468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel ENG gene mutation (c.1550_1551dupTG, p.S518*) in a Chinese family with hereditary hemorrhagic telangiectasia.
    Chen F; Yang M; Wen Z; Yu C
    Med Clin (Barc); 2021 Dec; 157(11):537-541. PubMed ID: 34728086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical genetic analysis and diagnosis of a family with hereditary hemorrhagic telangiectasia].
    Song XY; Yang YJ; Yao Y; Zhang Y; Song XC
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Dec; 56(12):1307-1312. PubMed ID: 34963219
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for the founder effect of a novel ACVRL1 splice-site mutation in Hungarian hereditary hemorrhagic telangiectasia families.
    Major T; Gindele R; Szabó Z; Alef T; Thiele B; Bora L; Kis Z; Bárdossy P; Rácz T; Havacs I; Bereczky Z
    Clin Genet; 2016 Nov; 90(5):466-467. PubMed ID: 27291782
    [No Abstract]   [Full Text] [Related]  

  • 20. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
    Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
    Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.